@article{APS9253,
author = {Qing LIU and Ming-wei WANG},
title = {Histone lysine methyltransferases as anti-cancer targets for drug discovery},
journal = {Acta Pharmacologica Sinica},
volume = {37},
number = {10},
year = {2017},
keywords = {},
abstract = {Post-translational epigenetic modification of histones is controlled by a number of histone-modifying enzymes. Such modification regulates the accessibility of DNA and the subsequent expression or silencing of a gene. Human histone methyltransferases (HMTs)constitute a large family that includes histone lysine methyltransferases (HKMTs) and histone/protein arginine methyltransferases (PRMTs). There is increasing evidence showing a correlation between HKMTs and cancer pathogenesis. Here, we present an overview of representative HKMTs, including their biological and biochemical properties as well as the profiles of small molecule inhibitors for a comprehensive understanding of HKMTs in drug discovery.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/9253}
}